BioVersys receives €20M in EU financing to support new antibiotics development

The European Investment Bank (EIB) and BioVersys AG, a clinical-stage pharmaceutical company developing treatments ...

April 14, 2021 | Wednesday | News
Seegene begins exporting new COVID-19 variant tests worldwide

Seegene Inc., a biotech company specializing in molecular diagnostics, has announced that it has obtained an export perm...

April 14, 2021 | Wednesday | News
Sputnik V vaccine receives authorization in India

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that Drug Controller General o...

April 13, 2021 | Tuesday | News
GSK to provide fill and finish capacity for Novavax’ COVID-19 vaccine

  Novavax Inc, GlaxoSmithKline (GSK) and the UK Government Vaccines Taskforce have reached an agreement i...

April 12, 2021 | Monday | News
Celonic and CureVac to manufacture 100 Million doses of CVnCoV

Germany based CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on mess...

April 12, 2021 | Monday | News
Australia approves wider storage conditions for Pfizer COVID-19 vaccine

The Therapeutic Goods Administration (TGA) in Australia has recently approved wider storage and transportation condition...

April 12, 2021 | Monday | News
CanSinoBIO's single-dose COVID-19 vaccine gets approval in Chile

China based CanSino Biologics Inc. has announced that the Instituto de Salud Pública de ...

April 9, 2021 | Friday | News
UK encourages England residents to opt for cost-free COVID-19 rapid test twice weekly

UK government has announced access to free, regular, rapid coronavirus testing from 9 April to everyone in England. In ...

April 8, 2021 | Thursday | News
South Korea approves J&J COVID-19 vaccine

South Korea’s Food and Drug Safety Ministry has granted final approval for the use of Johnson & Johnson’...

April 7, 2021 | Wednesday | News
European countries adopt indoor Photocatalytic nano-coating to fight COVID-19

Finland's nanotechnology company Nanoksi Finland has introduced a self-disinfecting nanocoating that reduces the number ...

April 7, 2021 | Wednesday | News
International researchers identifies a globally accessible treatment strategy for COVID-19

An international research collaboration involving researchers from the National University Cancer Institute, Singapore (...

April 1, 2021 | Thursday | News
Daiichi Sankyo starts Ph 1 Trial for Nafamostat Inhalation Formulation to treat COVID-19

Daiichi Sankyo, based in Japan, has announced that it has initiated in Japan a first-in-human phase 1 trial for nafamost...

April 5, 2021 | Monday | News
BD receives EUA for rapid Ag test to screen asymptomatic individuals

BD (Becton, Dickinson and Company), a leading global medical technology company, has announced that U.S. Food and D...

April 6, 2021 | Tuesday | News
ADB approves $450 M loan to help Indonesia deliver effective COVID-19 vaccines

The Asian Development Bank (ADB) has approved a $450 million loan to Indonesia to help Bio Farma, a state-owned vaccine ...

April 5, 2021 | Monday | News
Viet Nam launches COVID-19 prevention and control products

Students and scientists at the Viet Nam National University Ho Chi Minh City (VNUHCM) have carried out extensi...

April 2, 2021 | Friday | News
Sinovac announces annual capacity of 2 B doses of COVID-19 vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced that the third production...

April 2, 2021 | Friday | News
Novacyt receives CE-Mark for COVID-19 detection kit for 6 variants

Novacyt, a Paris-based international specialist in clinical diagnostics, announced that the Company will launch SNPsig&r...

April 1, 2021 | Thursday | News
Taiwan and India discuss smart pandemic prevention system

On March 24, 2021, Taiwan and India discussed jointly the development of a smart pandemic prevention system in...

April 1, 2021 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls